Absorption: Well absorbed following oral administration.
Distribution: Binds extensively to red blood cells.
Protein Binding: 40%.
Half-Life: 63 hr (plasma).
ROUTE | ONSET | PEAK | DURATION |
---|---|---|---|
PO | unknown | 26 hr | 24 hr |
‡Requires 2 wk of dosing to achieve steady-state blood levels.
Contraindicated in:
Use Cautiously in:
Resp: cough, pharyngitis
GI: anorexia, nausea, vomiting
F and E: metabolic acidosis
GU: kidney stones
Derm: STEVENS-JOHNSON SYNDROME, TOXIC EPIDERMAL NECROLYSIS, oligohydrosis (↑ in children), rash
Neuro: abnormal gait, hyperasthesia, incoordination, tremor
Misc: DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS (DRESS)
Drug-drug:
Lab Test Considerations:
NDC Code